Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

(2013) Andrzej Surdacki et al.   Cardiovascular Diabetology

Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo

(2013) Paolo Tessari et al.   DIABETES

What do we learn from measurements of HOMA-IR?

(2013) G. M. Reaven   DIABETOLOGIA

Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion

(2013) A. Natali et al.   DIABETOLOGIA

Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance

(2013) T Dimitroulas et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Coronary angiographic scoring systems: An evaluation of their equivalence and validity

(2012) Ian J. Neeland et al.   AMERICAN HEART JOURNAL

Left atrial volume index and aortic stiffness index in adult hemodialysed patients - link between compliance and pressure mediated by endothelium dysfunction; a cross-sectional study

(2012) Tomasz Zapolski et al.   BMC Cardiovascular Disorders

Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals

(2012) Ioannis Protopsaltis et al.   Cardiovascular Diabetology

Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study

(2012) Xuanqi An et al.   Cardiovascular Diabetology

Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?

(2012) Özben O. Işıklar et al.   CLINICAL BIOCHEMISTRY

Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study

(2012) Bob Siegerink et al.   Clinical Research in Cardiology

A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity

(2012) Francesco Andreozzi et al.   PLoS One

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study

(2011) Tse-Min Lu et al.   Cardiovascular Diabetology

Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery disease

(2011) Alexander Vonbank et al.   CLINICA CHIMICA ACTA

The Relationship Between Insulin Resistance and Incidence and Progression of Coronary Artery Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)

(2011) M. J. Blaha et al.   DIABETES CARE

Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography

(2011) Tse-Min Lu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine

(2010) Johannes Jacobi et al.   AMERICAN JOURNAL OF PATHOLOGY

Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S.

(2010) K. J. Ausk et al.   DIABETES CARE

Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks

(2009) Zeneng Wang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians

(2009) Aletta E Schutte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Endothelial dysfunction, ADMA and insulin resistance in essential hypertension

(2009) Francesco Perticone et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension

(2009) Renke Maas et al.   PHARMACOLOGICAL RESEARCH

Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk

(2009) Rainer H. Böger et al.   PHARMACOLOGICAL RESEARCH

Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort

(2009) Renke Maas et al.   STROKE

Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity

(2008) Karsten Sydow et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians

(2008) Erdembileg Anuurad et al.   ATHEROSCLEROSIS

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

(2008) M. Loredana Marcovecchio et al.   CLINICAL SCIENCE

Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina

(2008) A. Surdacki et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION